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T cells exacerbate lyme Borreliosis 
in Tlr2-Deficient Mice
Carrie E. Lasky, Carmela L. Pratt, Kinsey A. Hilliard, John L. Jones and Charles R. Brown*
Department of Veterinary Pathobiology, University of Missouri, Columbia, MO, USA
Infection of humans with the spirochete, Borrelia burgdorferi, causes Lyme borreliosis 
and can lead to clinical manifestations such as arthritis, carditis, and neurological 
conditions. Experimental infection of mice recapitulates many of these symptoms 
and serves as a model system for the investigation of disease pathogenesis and 
immunity. Innate immunity is known to drive the development of Lyme arthritis and 
carditis, but the mechanisms driving this response remain unclear. Innate immune 
cells recognize B. burgdorferi surface lipoproteins primarily via toll-like receptor (TLR)2; 
however, previous work has demonstrated TLR2−/− mice had exacerbated disease and 
increased bacterial burden. We demonstrate increased CD4 and CD8 T cell infiltrates 
in B. burgdorferi-infected joints and hearts of C3H TLR2−/− mice. In vivo depletion of 
either CD4 or CD8 T cells reduced Borrelia-induced joint swelling and lowered tissue 
spirochete burden, whereas depletion of CD8 T cells alone reduced disease severity 
scores. Exacerbation of Lyme arthritis correlated with increased production of CXCL9 
by synoviocytes, and this was reduced with CD8 T cell depletion. These results 
demonstrate T cells can exacerbate Lyme disease pathogenesis and prolong disease 
resolution possibly through dysregulation of inflammatory responses and inhibition of 
bacterial clearance.
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inTrODUcTiOn
Lyme disease is the most commonly reported vector-borne illness in the United States, with an 
estimated 300,000 new cases each year (1). It is caused by infection with the spirochete, Borrelia 
burgdorferi (Bb), and is transmitted by Ixodes ticks (2). Humans infected with B. burgdorferi typically 
develop an expanding circular rash called erythema migrans as an early sign of infection (3). If not 
treated with antibiotics early during the infection, the spirochetes disseminate and colonize other 
tissues, potentially resulting in arthritis, carditis, or neurological disease that may be difficult to 
treat clinically (4). Despite much effort, the mechanisms B. burgdorferi uses to evade host immune-
mediated clearance and persist in tissues resulting in disease pathogenesis are unclear and the focus 
of many infectious disease researchers.
In mice, innate immunity is considered to be the primary driver of Lyme arthritis and car-
ditis pathogenesis (5, 6). Genetic control of disease resistance or susceptibility was shown to be 
independent of adaptive immunity (7). Innate phagocytes recognize B. burgdorferi primarily 
through TLR2-mediated recognition of spirochete surface lipoproteins (8). It was hypothesized 
that TLR2−/− mice would display an attenuated disease phenotype upon infection with B. burg-
dorferi. Surprisingly, TLR2−/− mice had increased Lyme arthritis severity in both disease-resistant 
C57BL/6 mice and -susceptible C3H/HeJ mice (9, 10). This response was attributed to an increased 
spirochete load in the tissues of TLR2−/− mice. However, increasing the infectious dose in WT 
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mice does not increase arthritis severity, except in BALB/c mice 
(11). In addition, arthritis susceptibility has been demonstrated 
to be independent of spirochete loads in joint tissues (11, 12). 
Following infection of TLR2−/−/scid double mutant mice, Lyme 
arthritis severity was returned to WT control levels, suggesting 
a role for adaptive immune cells in driving the exacerbated dis-
ease severity in TLR2−/− mice (13). Subsequent work identified 
an increased presence of T cells in the joints of B. burgdorferi-
infected C3H TLR2−/− mice, suggesting that these cells may drive 
the increased pathology in TLR2−/− mice (14). In addition, it 
was demonstrated that increased T cell infiltration into mouse 
joints was correlated with increased production of IFN-induced 
chemokines (CXCL9 and CXCL10) by synoviocytes. However, 
the exact role of increased T cell presence in the joints of TLR2−/− 
mice was not defined.
In the current study, we advanced this line of inquiry by 
depleting CD4+ or CD8+ T cells in C3H TLR2−/− mice infected 
with B. burgdorferi. We found that CD8+ T cells were increased 
in the joints of TLR2−/− mice, whereas both CD8+ and CD4+ 
T cells were increased in infected hearts. Depletion of both T cell 
subsets decreased ankle swelling and joint spirochete loads, but 
only CD8+ T cell depletion lowered arthritis or carditis severity 
scores. These results highlight the complex regulatory mecha-
nisms that drive disease development and suggest CD8+ T cells 
may have an underappreciated role in driving Lyme disease 
pathology.
MaTerials anD MeThODs
animals
Female C3H/HeJ mice 4–6  weeks of age were purchased from 
The Jackson Laboratory (Bar Harbor, ME, USA). C3H TLR2−/− 
mice at the N6 generation backcross were generously provided 
by Dr. Linda Bockenstedt (Yale University) and these were fully 
backcrossed onto the C3H/HeJ background (N10) in our colony. 
Animals were given sterile food and water ad libitum and housed 
in a specific pathogen-free facility. All works were done in accord-
ance with the Animal Care and Use Committee of the University 
of Missouri.
Bacteria and infections
Frozen stocks of a virulent, passage 8, clonal isolate of B. burgdor-
feri N40 strain were used for all infections. Stocks were added to 
7-mL C-BSK-H medium (Sigma–Aldrich, St. Louis, MO, USA) 
and grown to log phase at 32°C. Spirochetes were enumerated 
using dark field microscopy and a Petroff–Hausser counting 
chamber (Hausser Scientific, Horsham, PA, USA). Spirochete 
dilutions were made in sterile BSK-H medium such that each 
mouse was inoculated in each hind foot pad with 50-μL medium 
containing 5 × 104 spirochetes.
antibodies and reagents
Antibodies for use in flow cytometry were obtained from eBio-
science (CD45.2-PerCPCy5.5, CD16/CD32, CD3e-PEeFl.610, 
CD4-APCeFl.780, CD335-APCeFl.780, CD122-PECy7, IFN-γ-
PerCPCy5.5, and F4/80-APCeFl.780) and Leinco (CD8-FITC 
and Ly6g-APC). Depleting antibodies were obtained from 
Leinco (GK1.5 for anti-CD4-depleting antibody and YTS-169 
for anti-CD8-depleting antibody) and graciously donated by 
Dr. Helen Mullen (University of Missouri) (YTS-156 anti-CD8-
depleting antibody). Collagenase/dispase Version 16 was pur-
chased from Roche and resuspended according to manufacturer’s 
directions. DNaseI DN-25 was purchased from Sigma and stored 
at −20°C in 2 mg/mL 50% glycerol and 75 mM NaCl.
In Vivo Depletion of T cell subsets
C3H TLR2−/− and WT C3H mice were treated with 400-μg 
CD8-depleting antibody (15) or 300-μg CD4-depleting antibody 
(16) i.p. 1 day prior to infection. As a negative control, mice were 
treated with sterile saline i.p. Every 7 days, CD8 or CD4 depletion 
was maintained by giving an additional i.p. injection of 250 or 
100 μg antibody, respectively.
cell isolation for Flow cytometry
C3H TLR2−/− and C3H WT mice were infected with B. burgdor-
feri and sacrificed at days 14, 21, 28, 42, and 49 postinfection. 
Hearts were perfused with 1× PBS, removed, and cut into fine 
pieces. Ankles were harvested from each mouse by removing 
the toes and carefully cutting through the knee joint, par-
ticularly to avoid bone marrow contamination. Excess muscle 
tissue was trimmed to reduce blood contamination. Ankles and 
hearts from each mouse were placed in appropriately labeled 
15-mL conical tubes containing 5  mL 1× PBS  +  4% FBS, 
75 μL diluted DNaseI (0.03 mg), and 50 μL stock collagenase/
dispase. These were placed on a rocker at room temperature 
for 1 h before being placed into sterile Petri dishes with 5 mL 
of additional RPMI supplemented with 10% FBS. Ankle tissue 
was carefully flayed apart using sterile rat tooth forceps. Cells 
from joints and hearts were strained through a 70-μm filter (BD 
Falcon) into a 50-mL conical tube. Cells were spun at 300  g, 
4°C, 8 min. Supernatant was removed, and cells were washed 
with 5-mL 1× PBS  +  4% FBS three times. Live cells were 
counted using 3% acetic acid with methylene blue (Stemcell 
Technologies).
Flow cytometric analysis
For flow cytometry, cells were stained for cell-specific markers. 
A total of 1  ×  106 cells from each sample were placed in a 
96-well U-bottom plate and Fc receptors blocked with anti-
CD16/CD32 for 15  min at 4°C. Cells were then incubated 
with cell-specific marker antibodies listed above for 30 min on 
ice and then washed and fixed in 1% paraformaldehyde for 
15 min. Cell analysis was run on a Dako Cyan flow cytometer 
using Summit V5.0 software. Samples were first gated on live 
cells, and then doublets were removed. Hematopoietic cells 
were selected by gating on CD45.2+ cells and then specific cell 
types within that gate were analyzed. For T cells, CD3e+ cells 
were selected and then CD4+ or CD8+ cell percentages were 
determined from the total CD3+ cell population. Total cell 
numbers were determined by multiplying the total cells counted 
in the homogenized tissue ×  percent CD45.2+ cells ×  percent 
cell-lineage-specific marker. For T cells, the total cells in the 
homogenized tissue × percent CD45.2+ cells × percent CD3e+ 
cells × percent CD4+ or CD8+ cells.
FigUre 1 | arthritis development and T cell infiltrates in Tlr2−/− mice. (a) Ankle diameters of WT and TLR2−/− mice were measured weekly following footpad 
inoculation with 5 × 104 B. burgdorferi. At each indicated time point, three mice per strain were sacrificed and numbers of CD3e+ T cells were determined from (B) 
ankles or (c) hearts by flow cytometry. Data are representative of two separate experiments. Symbols represent means ± SD. *p > 0.01 compared to WT control 
from same time point.
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assessment of arthritis and carditis 
Pathology
Ankle swelling was measured throughout the infection at the 
thickest craniocaudal portion of the joint using a metric caliper. 
Arthritis and carditis severity scores were determined, as described 
previously (17). Zinc–formalin-fixed, paraffin-embedded sec-
tions of ankle joints and hearts were stained with hematoxylin 
and eosin (H&E) and evaluated in a blinded manner on a scale 
of 0–4 with 0 representing no inflammation and 4 representing 
severe inflammation in more than half of the section evaluated.
Determination of B. burgdorferi loads
DNA was extracted from bladders of untreated, CD4-depleted, 
and CD8-depleted TLR2−/− and WT mice by homogenization in 
TRIzol as per manufacturer’s instructions. Real-time PCR reac-
tions for B. burgdorferi flagellin normalized to copies of mouse 
nidogen within the same sample were performed using TaqMan 
Universal PCR Master Mix (Applied Biosystems). Borrelia loads 
are expressed as copies of flagellin per 1000 copies of nidogen as 
described (18).
Determination of antibody levels
Sera of infected animals were collected at sacrifice by cardiac 
puncture and B. burgdorferi-specific IgM and IgG levels were 
detected using enzyme-linked immunosorbent assays (ELISAs) 
on Immulon 2B ELISA plates as described (10).
Determination of cytokine levels in 
Tissues
Protein was extracted from joint or heart tissue, as described 
previously (18). Briefly, joint and heart samples were excised and 
immediately flash frozen in liquid nitrogen. The samples were 
wrapped in foil and pulverized with a hammer. The resultant 
powder was resuspended in HBSS-containing 0.2% protease 
inhibitor mixture (Sigma) and 0.4% Triton X-100. Samples were 
homogenized using a tissue homogenizer, and particles removed 
by centrifugation and filtration through a 0.45-μm filter. Samples 
were brought to 1.5 mL in homogenization buffer. Protein levels 
were determined using a BCA assay (Pierce), and cytokine levels 
were determined using a Cytokine Mouse 20-Plex Panel (Life 
Technologies).
statistical analysis
Statistical analyses were performed using Graphpad Prism 
software. For single comparisons, an unpaired Student’s t-test 
was performed, and for non-parametric data, we used Mann–
Whitney. Multiple comparisons were performed using ANOVA 
and Tukey post  hoc test or Dunnett’s test for comparison to a 
single control (α = 0.05 for all tests).
resUlTs
increased T cell infiltration in Tlr2−/− Mice
Intradermal inoculation of B. burgdorferi into C3H TLR2−/− mice 
results in exacerbated arthritis compared with WT C3H and has 
been correlated with increased numbers of T cells within the joint 
tissue (9, 14). To investigate this phenomenon further, we infected 
C3H WT and C3H TLR2−/− mice with B. burgdorferi in both rear 
footpads and followed the development of arthritis. By the second 
week of infection, the TLR2−/− mice displayed significantly greater 
ankle swelling than the WT control mice, and this exacerbated 
response continued past day 35 postinfection (Figure 1A). Mice 
were sacrificed at various time points, and ankle and heart tissues 
were processed into single cell suspensions for analysis by flow 
cytometry. In agreement with a previous report, we found that 
T cells (CD3+ cells) were significantly increased in joint tissue 
from TLR2−/− mice (Figure 1B). In addition, we also found that 
T cells were also increased in the inflammatory infiltrates in the 
hearts of B. burgdorferi-infected mice (Figure 1C). Thus, T cells 
are increased in the inflammatory infiltrates in Lyme arthritis and 
carditis in TLR2−/− mice.
The previous report by Wang et al. (14) did not report the 
phenotype of the T cells in the increased inflammatory infiltrate 
in TLR2−/− mice. Therefore, we next investigated the levels of 
CD4+ and CD8+ T cell phenotypes in the joints and heart tissue 
using flow cytometry. CD4+ and CD8+ T cells were identified 
FigUre 2 | T cell subsets in infected ankle and heart tissue. WT and TLR2−/− mice were infected with B. burgdorferi and three mice from each strain sacrificed 
at the indicated time points. T cell subsets in ankle (a,c) and heart (B,D) tissue were characterized for CD4 (a,B), CD8 (c,D) by flow cytometry. Data are 
representative of two separate experiments. Bars represent means + SD. *p > 0.05 compared to WT control from same time point.
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from CD45.2+ CD3e+ T cells. Foxp3+ T regulatory cells could 
not be identified in either joint or heart cellular infiltrates 
(data not shown). Within both the ankle joint and heart tissue, 
CD4+ T cells made up the majority of the T cells in both WT 
and TLR2−/− mice (Figure 2). However, whereas CD4+ T cells 
in the joints of TLR2−/− mice were reduced compared to their 
WT counterparts, in the heart, CD4+ cells were increased dra-
matically near the peak of inflammation (Figures 2A,B). CD8+ 
T cell numbers trended higher at all time points evaluated within 
the joints and were significantly elevated in the TLR2−/− mice at 
day 28 postinfection (Figure 2C). In the hearts, CD8+ T cells 
mirrored the increase in CD4+ cells and significantly increased 
near the peak of inflammation (Figure 2D). These results dem-
onstrate that lymphocytes can be differentially recruited into 
B. burgdorferi-infected tissues as has been demonstrated for 
macrophages and neutrophils (19, 20). In addition, CD8+ T cell 
numbers are increased in the joints of B. burgdorferi-infected 
TLR2−/− mice, while both CD4+ and CD8+ cells were increased 
in the infected hearts.
We also investigated the presence of natural killer T (NKT) 
cells within the joint or heart tissue of B. burgdorferi-infected 
TLR2−/− mice. NKT cells have been reported to play a role 
in host defense in both Lyme arthritis and carditis (21, 22). 
In addition, we also examined the numbers of natural killer 
(NK) cells in the joints and hearts of TLR2−/− mice, as these 
cells have been implicated in the exacerbated development 
of Lyme arthritis in C57BL/6 IL-10−/− mice (23). We therefore 
looked for both NK (CD45.2+NKp46+CD122+CD3e−) and NKT 
(CD45.2+NKp46+CD122+CD3e+) cells in the infected tissues at 
day 21 postinfection using flow cytometry. Within the infected 
ankle joints, both NK and NKT cells were significantly decreased 
in TLR2−/− mice compared to WT mice (Figures 3A,B). Within 
the infected heart tissue, the numbers of NK cells and NKT cells 
were quite low and did not differ between WT and TLR2−/− mice 
(Figures 3C,D). These results suggest that neither NKT nor NK 
cells are likely responsible for the increased disease severity seen 
in the TLR2−/− mice.
In Vivo T cell subset Depletion in Tlr2−/− 
Mice reduces lyme arthritis to WT levels
C3H WT and C3H TLR2−/− mice were depleted of either 
CD4+ or CD8+ T cells using intraperitoneal injections of either 
CD4+ or CD8+ T cell-depleting antibodies. Flow cytometry 
demonstrated the efficacy of the treatment (Figure 4A). One 
FigUre 3 | nK and nKT cells in infected ankle and heart tissue. WT and TLR2−/− mice were infected with B. burgdorferi and three mice from each strain 
sacrificed at the indicated time points. NK (CD45.2+NKp46+CD122+CD3e−) and NKT (CD45.2+NKp46+CD122+CD3e+) cells were enumerated in ankle (a,B) and 
heart (c,D) tissue at day 21 postinfection. Data are representative of two separate experiments. Bars represent means + SD. *p > 0.05 compared to WT control 
from same time point.
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day after administration of depleting antibodies, mice were 
infected with 1 ×  105 B. burgdorferi via footpad inoculation. 
T cell depletion was maintained by weekly administration 
of depleting antibody throughout the infection time course. 
Ankle swelling was monitored every 7 days. WT mice depleted 
of either CD4+ or CD8+ T cells had slightly reduced swelling 
at all time points assessed compared to saline-treated controls, 
but these differences did not reach statistical significance 
(Figure 4B). TLR2−/− mice depleted of CD4+ or CD8+ T cells 
had significantly reduced ankle swelling compared to untreated 
controls, and the ankle diameter increase was similar to that 
typical of WT mice (compare Figures  4B,C). In the experi-
ment shown, the anti-CD4 treated all died between days 21 
and 28 postinfection. In a subsequent experiment, the anti-
CD4-treated mice had a similar reduction in ankle swelling, 
but the mice did not die. The reason for this discrepancy is 
unknown, but in both instances the T cell depletion resulted 
in a significant decrease in ankle swelling. Figure 4D shows a 
representative ankle from a TLR2−/− CD8-depleted mouse and 
a saline-treated TLR2−/− control mouse at day 14 postinfec-
tion. The joint swelling in the CD8+ T cell-depleted TLR2−/− 
mouse is dramatically reduced compared to the saline-treated 
TLR2−/− mouse. A similar reduction was seen in the CD4+ 
T cell-depleted mice (data not shown).
Sections of both ankle joint and heart tissue from control-
treated and T cell-depleted TLR2−/− mice were processed for 
histology by H&E staining and scored for arthritis and carditis 
severity (17). As previously reported, arthritis severity scores 
in TLR2−/− mice were significantly increased over WT control 
mice at day 21 postinfection (Figure 5A). Depletion of CD4+ or 
CD8+ T cell subsets had little effect on arthritis severity scores, 
with values similar to WT control-treated mice. In contrast, 
depletion of CD8+ T cells, but not CD4+ T cells, decreased 
arthritis severity scores to similar levels as WT mice. CD4+ T cell 
severity scores remained high, similar to the TLR2−/− mice. In the 
hearts, carditis severity was not increased in the TLR2−/− mice 
compared to the WT control-treated mice (Figure 5B). Again, 
as in the joints, depletion of CD4+ T cells had no effect on 
carditis severity scores in either WT or TLR2−/− mice. Depletion 
of CD8+ T cells, however, lowered carditis severity in both the 
WT and TLR2−/− mice, indicating a role for CD8+ T cells in 
carditis severity. Increased arthritis severity in TLR2−/− mice 
has been linked to an increase in spirochete burden in joint 
tissue (10). B. burgdorferi loads in tissue were significantly 
higher in the TLR2−/− control mice than in the WT control 
mice (Figure 5C). Depletion of T cell subsets had little effect on 
spirochete levels in WT mice, but significantly lowered Borrelia 
loads in the TLR2−/− mice compared with TLR2−/− control mice. 
FigUre 4 | lyme arthritis in mice depleted of cD4 or cD8 T cells. Mice were treated with saline (control), CD4-depleting antibody, or CD8-depleting antibody 
and infected with B. burgdorferi. Flow cytometry plots demonstrate depletion of CD4+ and CD8+ T cells 6 days posttreatment (a). Arthritis development was monitored 
over time for WT (B) and TLR2−/− (c) mice. Representative pictures of TLR2−/− mice depleted of CD8 T cells or saline treated were taken at day 14 postinfection 
(D). Data are representative of two separate experiments. n = 3, symbols represent means ± SD. *p > 0.01 compared to WT control from same time point.
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FigUre 5 | arthritis and carditis severity scores. Mice were infected and treated as in Figure 4. On day 21 postinfection, the mice were sacrificed and ankles 
(a) and hearts (B) were processed for histology and scored for lesion severity. Levels of B. burgdorferi in tissue were determined by qRT-PCR (c). Data are 
representative of two separate experiments. n = 8, bars represent means ± SD. * vs. TLR2−/− control, ** vs. WT CD4 or CD8-depleted mice, *** vs. WT control, p > 0.05.
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B. burgdorferi loads in the CD4+ and CD8+ T cell-depleted mice 
were still above levels in T  cell-depleted WT mice. Thus, the 
defect in spirochete clearance in TLR2−/− mice can be mitigated 
by the removal of either CD4+ or CD8+ T cells, but does not 
return them to WT control levels.
Production of Borrelia-specific antibodies has been reported 
to be normal in TLR2−/− mice (10). We investigated the effect 
T cell subset depletion might have on their production. As previ-
ously reported, levels of Borrelia-specific IgM were not altered 
in TLR2−/− mice, and there was no effect of T cell depletion on 
their production (Figure 6A). Similarly, levels of Borrelia-specific 
IgG were no different between WT control and TLR2−/− mice 
(Figure  6B). However, CD4+ T cell depletion significantly 
decreased Borrelia-specific IgG levels in both strains of mice and, 
thus, was not specific to the TLR2 deficiency, but rather more 
likely to the lack of T cell help for B cell class switching. CD8+ 
T cell depletion had no effect on IgG levels in either the WT or 
TLR2−/− mice.
Neutrophils are the predominant inflammatory cell type in 
the joint in mice during Lyme arthritis, and both neutrophil and 
macrophage levels increase in the B. burgdorferi-infected joints 
of TLR2−/− mice (14). We therefore investigated the effect of 
T cell subset depletion on neutrophil and macrophage numbers in 
the joints of WT and TLR2−/− mice at day 21 postinfection using 
flow cytometry. Ly6ghi cells, representative of mature neutrophils, 
were significantly increased in control TLR2−/− mice compared 
to control WT mice (Figure 7A). Interestingly, following either 
CD4+ or CD8+ T cell depletion, neutrophil numbers in joints of 
WT control mice were significantly increased, although this did 
not result in an increase in arthritis severity (Figure 5A). In con-
trast, depletion of either CD4+ or CD8+ T cells in TLR2−/− mice 
resulted in a reduction of neutrophil numbers to levels similar 
to the WT controls. Similar results were seen for macrophage 
numbers in the B. burgdorferi-infected joints, except that CD4+ 
T cell depletion in WT mice did not increase macrophage levels 
(Figure 7B). These results demonstrate that depletion of T cell 
subsets in WT mice increases the recruitment of neutrophils 
and macrophages into the B. burgdorferi-infected joint, but does 
not increase arthritis severity. In contrast, TLR2−/− mice have 
exacerbated levels of neutrophils and macrophages in the infected 
FigUre 7 | neutrophil and macrophage numbers in infected ankle joints. Mice were infected and treated as in Figure 4. On day 21 postinfection, the mice 
were sacrificed and neutrophil (a) and macrophage (B) numbers were assessed from joint tissue. Data are representative of two separate experiments. n = 3, bars 
represent means ± SD. *p > 0.05.
FigUre 6 | Borrelia-specific antibody production. Mice were infected and treated as in Figure 4. On day 21 postinfection, the mice were sacrificed and 
assessed for B. burgdorferi-specific IgM (a) and IgG (B) levels in serum. Data are representative of two separate experiments. n = 3, bars represent means ± SD. 
*p > 0.05 compared to mouse strain control.
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joints, and these levels are decreased with T cell depletion, but 
only CD8+ T cell depletion appears to lower arthritis severity.
Bone marrow-derived macrophages from TLR2−/− mice 
were defective in their production of IL-6, IL-10, and TNFα 
when stimulated in vitro with B. burgdorferi recombinant outer 
surface proteins or sonicated spirochetes (10). In contrast, 
transcripts from several interferon-inducible chemokine genes 
were increased in joints of B. burgdorferi-infected mice (14). We 
therefore measured the levels of 20 chemokines and cytokines 
from the infected joints of control and CD4+ or CD8+ T cell-
depleted WT and TLR2−/− mice at day 21 postinfection using 
a bead assay system. Most of the cytokines measured were 
present at low levels, and there were no statistically significant 
differences between the WT control and TLR2−/− mice (data not 
shown). Interferon-gamma levels are shown as a representative 
cytokine for this analysis (Figure  8A). No significant differ-
ences were seen between untreated or T cell-depleted WT 
and TLR2−/− mice. We also looked at an earlier time point, 
as we have previously shown that many pro-inflammatory 
mediators peak earlier during Lyme arthritis (18). Analysis of 
IFN-γ levels in ankle joints at day 7 postinfection yielded no 
difference between control WT and TLR2−/− mice (data not 
shown). The only inflammatory mediator that we found to be 
significantly altered in the joints of the TLR2−/− mice was CXCL9 
(Figure 8B). Depletion of CD4+ T cells had no effect on the levels 
of CXCL9, but CD8+ T cell depletion dramatically reduced the 
level of CXCL9 within the joints, although this reduction was 
not statistically significant. Transcripts of CXCL10 were also 
reported to increase in joints of TLR2−/− mice infected with 
B. burgdorferi (14), although we found no difference in protein 
FigUre 8 | cytokine production in joints of infected mice. Mice were infected and treated as in Figure 4. On day 21 postinfection, the mice were sacrificed 
and levels of IFNγ (a), CXCL9 (B), and CXCL10 (c) were determined from homogenized joint tissue using a Lumina assay. CXCL9 levels within ICAM-1+VCAM-
1+CD14− synoviocytes were assessed from TLR2−/− mice at 14 days postinfection by flow cytometry (D). n = 3, data representative of one trial. Bars represent 
means ± SD. *p > 0.01 compared to WT control.
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levels in our study (Figure  8C). Synovial cell production of 
CXCL9- and CXCL10-mediated T  cell recruitment and T cell 
production of mediators that stimulate synovial cell chemokine 
production set up a synergistic positive feedback loop that has 
been suggested to drive the enhanced inflammatory response in 
TLR2-deficient mice (14). We therefore examined the produc-
tion of CXCL9 from synoviocytes in vivo using flow cytometry. 
Ankle joints from B. burgdorferi-infected TLR2−/− mice at day 14 
postinfection were processed for flow cytometry. Synoviocytes 
(ICAM-1+V-CAM-1+CD14−) were found to produce CXCL9 
(Figure  8D). Depletion of CD4+ T cells had no effect on the 
production of CXCL9 by these cells; however, CD8+ T cell 
depletion caused about a 50% reduction in CXCL9 production. 
Due to the low numbers of animals in this experiment, this 
result was not statistically significant, but along with our previ-
ous data, suggests that CD8+ T cells are the cells responsible 
for the increased inflammation and arthritis severity seen in 
TLR2−/− mice infected with B. burgdorferi.
DiscUssiOn
Innate immune cells are the first line of defense against bacte-
rial infection and their responses guide the developing immune 
response. These cells use an arsenal of pattern recognition recep-
tors to recognize bacterial invaders and stimulate an appropriate 
response (24). Innate phagocytes recognize extracellular B. burg-
dorferi outer surface lipoproteins primarily via TLR1/2 heter-
odimers (8, 25) and possibly flagellin through TLR5 (26). Other 
intracellular receptors, such as NOD2, and endosomal TLRs 
(TLR7, TLR8, and TLR9) may also contribute to the response 
(27). Therefore, it was surprising when TLR2−/− mice were found 
to develop exacerbated Lyme arthritis (9, 10). This response was 
found to require adaptive immune cells (13) and correlated with 
increased recruitment of T cells into the infected joints (14). Here, 
we demonstrate that numbers of CD8+ T cells, but not CD4+ 
T  cells, were increased in the joints of B. burgdorferi-infected 
TLR2−/− mice, but both T cell subsets were increased in the hearts. 
While depletion of either subset could lower joint swelling and 
spirochete loads, only CD8+ T cell depletion lowered arthritis and 
carditis severity scores.
Similar to previous publications, we found that TLR2-deficient 
mice infected with B. burgdorferi displayed both increased 
ankle swelling and elevated numbers of CD3e+ T cells within 
joint tissue at all time points assessed. In infected WT mice, 
T cells typically make up about 2% of the hematopoietic cell 
population within the joints. In infected TLR2-deficient mice, 
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this percentage jumped to 10. In the hearts, we found a similar 
phenomenon; T cell numbers were elevated during carditis. 
The role of T cells in mediating Lyme disease pathogenesis has 
been debated for some time. In the mouse model, the balance of 
CD4+ T cell subsets (Th1/Th2) was suggested to mediate Lyme 
arthritis resistance or susceptibility through the production of 
IL-4 or IFNγ, respectively (28, 29). Treatment of C3H mice with 
anti-CD4-depleting antibody increased arthritis severity and 
treatment with anti-CD8-depleting antibody decreased arthritis 
severity, suggesting T cell responses could mediate Lyme disease 
pathogenesis (30). However, a subsequent study in arthritis resist-
ant C57BL/6 mice deficient in CD4+ cells showed no difference in 
the development of Lyme arthritis, but showed a delay in carditis 
resolution (31). Innate immunity was then shown to be capable 
of mediating both resistance and susceptibility to Lyme arthritis 
development (7). The small number of T cells in joints and hearts 
of B. burgdorferi-infected mice, however, suggests they might also 
have a role in shaping the developing immune response. This led 
to contrasting reports for the role of CD4+ T cells in Lyme arthritis 
and carditis. Adoptive transfer of CD4+ T cells into infected B6 
RAG−/− mice led to exacerbated arthritis and myocarditis (32), 
while similar adoptive transfer into B6 TCRα−/− mice resulted 
in no exacerbated disease and carditis resolution (33). These 
differences were suggested to be due to the differences in the 
lymphocyte compartment in the recipient mice and perhaps the 
induction of autoimmune disease (33). In the current study, we 
used serodepletion to remove CD4+ or CD8+ T cell subsets from 
naive WT or TLR2−/− mice. We found that depletion of CD4+ 
or CD8+ T cells had no effect on arthritis development in C3H 
mice, although depletion of CD8+ cells reduced carditis severity 
at 3  weeks postinfection. These results are similar to those of 
Fikrig et al. (31) and contrasting with those of Keane-Myers and 
Nickell (30). The reasons for these differences are not clear, but 
most likely are due to differences in antibody treatments and effi-
ciency of cell subset depletions. A role for CD8+ T cells in driving 
exacerbated disease in the TLR2−/− mice, however, has not been 
previously reported and may represent a new target for therapy 
as CD8+ T cells specific for Borrelia antigens have been reported 
in blood of patients with Lyme arthritis (34). We also looked the 
presence of T regulatory cells in the joints and hearts of WT and 
TLR2−/− mice, since these have been suggested to play a role in 
Lyme disease pathogenesis (35). T regulatory cells could not be 
found in either joint or heart tissue, and in the current, we did 
not look for γδT cells.
Natural killer cells are induced in mice following infection 
with B. burgdorferi, but their depletion had little effect on arthritis 
pathogenesis (36). They have been suggested to contribute to 
the increased inflammation seen in B6 IL-10−/− mice via their 
production of IFNγ (23). Prolonged NK cell activity has also 
been correlated with continued inflammation following antibi-
otic therapy in Lyme patients (37). We found decreased NK 
cell numbers in the joints of TLR2−/− mice and no change in 
heart tissue. Since there was no change in joint IFNγ levels in 
the TLR2−/− mice, it is unlikely the NK cells play a major role 
in the TLR2−/− mice. We found similar results for NKT cells. 
Low numbers of NKT cells were identified within infected joint 
tissue and almost none were found within heart tissue. NKT cells 
recognize bacterial glycolipids presented by CD1d (38), and 
infection of mice deficient in CD1 with B. burgdorferi led to 
impaired host defense, increased arthritis severity, and impaired 
spirochete clearance (39). NKT cells specifically recognize diacyl-
glycerol antigens from B. burgdorferi (40). They limit spirochete 
dissemination by killing blood-borne spirochetes in the liver (41) 
and act as a cytotoxic barrier to prevent spirochete entry into the 
joint space (42). Deletion of NKT cells resulted in more severe 
and prolonged arthritis and reduced ability to clear spirochetes 
from tissues (22). It is tempting to speculate that the reduced 
numbers of NKT cells in the infected joints of TLR2−/− mice 
might be responsible for the increased arthritis severity and 
spirochete loads in this tissue. However, how depletion of CD4+ 
or CD8+ cells, both of which are expressed on some NKT cell 
subsets, could reduce B. burgdorferi tissue loads and increase 
arthritis severity in the TLR2−/− mice is unclear. More work is 
needed in this area.
Both C57BL/6- and C3H TLR2-deficient mice infected with 
B. burgdorferi display significantly worse arthritis and carditis 
(14, 43), and we have shown this is mediated primarily by 
increased recruitment of CD8+ T cells into the infected joint. 
An increase in T cell numbers in the joints was associated with 
increased transcript levels of CXCL9 and CXCL10, giving a 
potential mechanism for the increased T cell recruitment (14). 
It was suggested that the enhanced arthritis of TLR2−/− mice 
was due to unregulated local chemokine production by syn-
oviocytes. We measured chemokine production directly from 
infected joints and found CXCL9 was significantly unregulated 
in the joints of B. burgdorferi-infected TLR2-deficient mice. 
Protein levels of CXCL10 were only slightly elevated and at 
much lower levels than CXCL9. In the absence of CD8+ T cells, 
CXCL9 levels were dramatically reduced, suggesting that 
CD8+ T cells activate synoviocytes to produce CXCL9, thereby 
recruiting additional T cells into the joint and driving increased 
inflammation in the TLR2−/− mice. CXCL9 production can 
be induced by either type I or type II IFN (44). Production 
of type I IFN has been linked to arthritis development in 
B.   burgdorferi-infected mice, and its production has been 
shown to be independent of TLR2 signaling (45). We measured 
levels of type II IFN (IFNγ) from the joints of B. burgdorferi-
infected mice and found they were similar between WT and 
TLR2−/− mice. Thus, the mechanism responsible for increased 
CXCL9 expression in the joints of TLR2−/− mice is still unclear 
and is currently being investigated.
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